These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6386253)

  • 21. A placebo-controlled study to determine the efficacy of oral disopyramide phosphate for the prophylaxis of ventricular dysrhythmias after acute myocardial infarction.
    Kumana CR; Rambihar VS; Tanser PH; Cairns JA; Gupta RN; Wildeman RA; Johnston M; Johnson AL; Gent M
    Br J Clin Pharmacol; 1982 Oct; 14(4):519-27. PubMed ID: 6753887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Propafenone versus disopyramide for treatment of chronic symptomatic ventricular arrhythmias. A multicenter study.
    Jonason T; Ringqvist I; Bandh S; Nilsson G; Nilsson H; Lidell C; Bjerle P; Olofsson BO
    Acta Med Scand; 1988; 223(6):515-23. PubMed ID: 3291557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the antiarrhythmic efficacy of mexiletine in patients with chronic ventricular arrhythmias.
    Van Durme JP
    Acta Cardiol Suppl; 1980; (25):121-5. PubMed ID: 6990664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the efficacy of propafenone versus disopyramide for complex premature ventricular contractions. Evaluation with long-term monitoring.
    Naccarella F; Palmieri M; del Corso P; Lombardi G; Bracchetti D
    Arzneimittelforschung; 1982; 32(5):547-50. PubMed ID: 7201833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose-related antiarrhythmic effects of nicainoprol in patients with chronic ventricular arrhythmias--a double-blind, placebo-controlled, cross-over multicentre trial. Nicainoprol Study Group.
    Schneider W; Reifart N; Blaeser A; Ostrowski J; Kaltenbach M; Kober G
    Eur Heart J; 1991 Aug; 12(8):900-8. PubMed ID: 1915428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical evaluation of antiarrhythmic effects of disopyramide by multiclinical controlled double-blind methods.
    Kimura E; Mashima S; Tanaka T
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(8):338-43. PubMed ID: 7409935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disopyramide in patients with ventricular premature beats: an experimental model and preliminary results.
    Hohansson BW; Persson S
    J Int Med Res; 1976; 4(1 Suppl):96-9. PubMed ID: 1026538
    [No Abstract]   [Full Text] [Related]  

  • 28. Prophylaxis against ventricular arrhythmias in suspected acute myocardial infarction: a comparison of tocainide and disopyramide.
    Allen-Narker RA; Roberts CJ; Marshall AJ; Jordan SC; Barritt DW; Goodfellow RM
    Br J Clin Pharmacol; 1984 Nov; 18(5):725-32. PubMed ID: 6439233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical studies of the antiarrhythmic efficacy of disopyramide phosphate (Norpace) (author's transl)].
    Smith WS
    Herz; 1978 Dec; 63(36):399-406. PubMed ID: 95482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Indications and surveillance of quinidine and disopyramide treatments].
    Gilgenkrantz JM; Aliot E; Maureira JJ
    Rev Prat; 1975 Oct; 25(45):3485-8, 3493-4. PubMed ID: 1209116
    [No Abstract]   [Full Text] [Related]  

  • 31. Mexiletine and quinidine in ventricular ectopy.
    Fenster PE; Hanson CD
    Clin Pharmacol Ther; 1983 Aug; 34(2):136-42. PubMed ID: 6347497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical studies of Norpace. Summarizing remarks.
    Fowler NO
    Angiology; 1975 Jan; 26(1 Pt 2):154-5. PubMed ID: 1090216
    [No Abstract]   [Full Text] [Related]  

  • 33. Serum drug concentrations and adverse effects in cardiac patients after administration of a new controlled-release disopyramide preparation.
    Zema MJ
    Ther Drug Monit; 1984; 6(2):192-8. PubMed ID: 6740739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antiarrhythmic effect of disopyramide in ventricular extrasystole and auricular fibrillation].
    Breithardt G; Haerten K; Seipel L
    Z Kardiol; 1976 Aug; 65(8):713-23. PubMed ID: 61664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparison between amiodarone and disopyramide in the treatment of ventricular extrasystoles].
    Gaudeau B; Badouraly A; Herpin D; Tournadre P; Boutaud P; Amiel A; Guillem JP; Demange J
    Ann Cardiol Angeiol (Paris); 1986 Jan; 35(1):43-8. PubMed ID: 2421631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crossover comparison of cibenzoline and quinidine in ambulatory patients with chronic ventricular arrhythmias.
    Mohiuddin SM; Woodruff MP; Esterbrooks DJ; Mooss AN; Hansen JM; Hilleman DE
    J Cardiovasc Pharmacol; 1989 Apr; 13(4):525-9. PubMed ID: 2470988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination of tocainide and quinidine for better tolerance and additive effects in patients with coronary artery disease.
    Kim SG; Mercando AD; Fisher JD
    J Am Coll Cardiol; 1987 Jun; 9(6):1369-74. PubMed ID: 3108345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficacy of quinidine and disopyramide in the maintenance of sinus rhythm after electroconversion from atrial fibrillation. A double-blind study comparing quinidine, disopyramide and placebo.
    Lloyd EA; Gersh BJ; Forman R
    S Afr Med J; 1984 Mar; 65(10):367-9. PubMed ID: 6367096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical studies of Norpace (Part XI).
    Nisbet T
    Angiology; 1975 Jan; 26(1 Pt 2):149-53. PubMed ID: 46729
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of acebutolol with propranolol, quinidine, and placebo: results of three multicenter arrhythmia trials.
    Chandraratna PA
    Am Heart J; 1985 May; 109(5 Pt 2):1198-204. PubMed ID: 3993535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.